Differential expression of lipid metabolism-related proteins in different breast cancer subtypes

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Kim, Sewha ^a   Lee, Yukyung ^a   Koo, Ja Seung ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A OXIDASE; ACYL COENZYME A OXIDASE 1; CARNITINE PALMITOYLTRANSFERASE I; CARNITINE PALMITOYLTRANSFERASE IA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FATTY ACID BINDING PROTEIN 4; FATTY ACID SYNTHASE; HORMONE SENSITIVE LIPASE; PERILIPIN; PERILIPIN 1; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; LUMINAL A BREAST CANCER; LUMINAL B BREAST CANCER; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROTEIN EXPRESSION; SURVIVAL RATE; TISSUE MICROARRAY; TRIPLE NEGATIVE BREAST CANCER; BREAST TUMOR; CANCER GRADING; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LIPID METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; PROPORTIONAL HAZARDS MODELS;

EID: 84928911843     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119473     Document Type: Article

References (41)

1. Warburg O (1956) On the origin of cancer cells. Science 123:309-314. PMID: 13298683
2. Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A, Saavedra E (2007) Energy metabolism in tumor cells. FEBS J 274:1393-1418. PMID: 17302740
3. Menendez JA, Lupu R (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7:763-777. PMID: 17882277
4. Kraemer FB, Shen WJ (2002) Hormone-sensitive lipase: control of intracellular tri-(di-) acylglycerol and cholesteryl ester hydrolysis. J Lipid Res 43:1585-1594. PMID: 12364542
5. Carracedo A, Cantley LC, Pandolfi PP (2013) Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer 13:227-232. doi: 10.1038/nrc3483 PMID: 23446547
6. Nomura DK, Long JZ, Niessen S, Hoover HS, Ng SW, et al. (2010) Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140:49-61. doi: 10.1016/j.cell.2009.11. 027 PMID: 20079333
7. Jones C, Nonni AV, Fulford L, Merrett S, Chaggar R, et al. (2001) CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. Br J Cancer 85:422-427. PMID: 11487275
8. Brglez V, Lambeau G, Petan T (2014) Secreted phospholipases A in cancer: Diverse mechanisms of action. Biochimie.
9. Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, et al. (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17:1498-1503. doi: 10.1038/nm.2492 PMID: 22037646
10. Greenberg AS, Egan JJ, Wek SA, Garty NB, Blanchette-Mackie EJ, et al. (1991) Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. J Biol Chem 266:11341-11346. PMID: 2040638
11. Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr (2013) Cellular fatty acid metabolism and cancer. Cell Metab 18:153-161. doi: 10.1016/j.cmet.2013.05.017 PMID: 23791484
12. Pucer A, Brglez V, Payre C, Pungercar J, Lambeau G, et al. (2013) Group X secreted phospholipase A (2) induces lipid droplet formation and prolongs breast cancer cell survival. Mol Cancer 12:111. doi: 10.1186/1476-4598-12-111 PMID: 24070020
13. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869-10874. PMID: 11553815
14. Pinheiro C, Sousa B, Albergaria A, Paredes J, Dufloth R, et al. (2011) GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. Histol Histopathol 26:1279-1286. PMID: 21870331
15. Choi J, Jung WH, Koo JS (2013) Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry. Pathobiology 80:41-52. doi: 10.1159/000339513 PMID: 22832328
16. Kim S, Kim Do H, Jung WH, Koo JS (2013) Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer. Endocr Relat Cancer 20:339-348. doi: 10.1530/ERC-12-0398 PMID: 23507704
17. Kim SK, Jung WH, Koo JS (2014) Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes. PLoS One 9:e101004. doi: 10.1371/journal.pone. 0101004 PMID: 24979213
18. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403-410. PMID: 1757079
19. Won KY, Kim GY, Kim YW, Song JY, Lim SJ (2010) Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer. Hum Pathol 41:107-112. doi: 10.1016/j.humpath.2009.07.006 PMID: 19762066
20. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, et al. (2010) American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784-2795. doi: 10. 1200/JCO.2009.25.6529 PMID: 20404251
21. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, et al. (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118-145. PMID: 17159189
22. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, et al. (2011) Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22:1736-1747. doi: 10.1093/annonc/mdr304 PMID: 21709140
23. Yang M, Xu SP, Ao QL (2013) [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast]. Zhonghua Bing Li Xue Za Zhi 42:257-261. doi: 10.3760/cma.j.issn. 0529-5807.2013.04.010 PMID: 23928534
24. Jin Q, Yuan LX, Boulbes D, Baek JM, Wang YN, et al. (2010) Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells. Breast Cancer Res 12:R96. doi: 10.1186/bcr2777 PMID: 21080941
25. Hilvo M, Denkert C, Lehtinen L, Muller B, Brockmoller S, et al. (2011) Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res 71:3236-3245. doi: 10.1158/0008-5472. CAN-10-3894 PMID: 21415164
26. Antalis CJ, Arnold T, Rasool T, Lee B, Buhman KK, et al. (2010) High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation. Breast Cancer Res Treat 122:661-670. doi: 10.1007/s10549-009-0594-8 PMID: 19851860
27. Brglez V, Pucer A, Pungercar J, Lambeau G, Petan T (2014) Secreted phospholipases A2 are differentially expressed and epigenetically silenced in human breast cancer cells. Biochem Biophys Res Commun 445:230-235. doi: 10.1016/j.bbrc.2014.01.182 PMID: 24508801
28. Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, et al. (2007) The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 13:2329-2334. PMID: 17438091
29. Reis-Filho JS, Tutt AN (2008) Triple negative tumours: a critical review. Histopathology 52:108-118. doi: 10.1111/j.1365-2559.2007.02889.x PMID: 18171422
30. Bieche I, Parfait B, Tozlu S, Lidereau R, Vidaud M (2001) Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene. Carcinogenesis 22:1521-1526. PMID: 11532875
31. Hancke K, Grubeck D, Hauser N, Kreienberg R, Weiss JM (2010) Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients. Breast Cancer Res Treat 119:367-367. doi: 10.1007/s10549-009-0577-9 PMID: 19842034
32. Isola JJ (1993) Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors. J Pathol 170:31-35. PMID: 8100853
33. Uehara H, Takahashi T, Oha M, Ogawa H, Izumi K (2014) Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression. Int J Cancer.
34. Chang H, Shyu KG, Lee CC, Tsai SC, Wang BW, et al. (2003) GL331 inhibits HIF-1alpha expression in a lung cancer model. Biochem Biophys Res Commun 302:95-100. PMID: 12593853
35. Yeo EJ, Chun YS, Cho YS, Kim J, Lee JC, et al. (2003) YC-1: a potential anticancer drug targeting hypoxiainducible factor 1. J Natl Cancer Inst 95:516-525. PMID: 12671019
36. Mohanti BK, Rath GK, Anantha N, Kannan V, Das BS, et al. (1996) Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int J Radiat Oncol Biol Phys 35:103-111. PMID: 8641905
37. Aft RL, Zhang FW, Gius D (2002) Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death. Br J Cancer 87:805-812. PMID: 12232767
38. Vullo D, Franchi M, Gallori E, Pastorek J, Scozzafava A, et al. (2003) Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett 13:1005-1009. PMID: 12643899
39. Gallagher SM, Castorino JJ, Wang D, Philp NJ (2007) Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDAMB-231. Cancer Res 67:4182-4189. PMID: 17483329
40. Lee JS, Sul JY, Park JB, Lee MS, Cha EY, et al. (2013) Fatty acid synthase inhibition by amentoflavone suppresses HER2/neu (erbB2) oncogene in SKBR3 human breast cancer cells. Phytother Res 27:713-720. doi: 10.1002/ptr.4778 PMID: 22767439
41. Puig T, Aguilar H, Cufi S, Oliveras G, Turrado C, et al. (2011) A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines. Breast Cancer Res 13:R131. doi: 10.1186/bcr3077 PMID: 22177475